Literature DB >> 21134381

Dynamic conformations of the CD38-mediated NAD cyclization captured in a single crystal.

HongMin Zhang1, Richard Graeff, Zhe Chen, Liangren Zhang, Lihe Zhang, Honcheung Lee, Quan Hao.   

Abstract

The extracellular domain of human CD38 is a multifunctional enzyme involved in the metabolism of two Ca(2+) messengers: cyclic ADP-ribose and nicotinic acid adenine dinucleotide phosphate. When NAD is used as substrate, CD38 predominantly hydrolyzes it to ADP-ribose, with a trace amount of cyclic ADP-ribose produced through cyclization of the substrate. However, mutation of a key residue at the active site, E146, inhibits the hydrolysis activity of CD38 but greatly increases its cyclization activity. To understand the role of the residue E146 in the catalytic process, we determined the crystal structure of the E146A mutant protein with a substrate analogue, arabinosyl-2'-fluoro-deoxy-nicotinamide adenine dinucleotide. The structure captured the enzymatic reaction intermediates in six different conformations in a crystallographic asymmetric unit. The structural results indicate a folding-back process for the adenine ring of the substrate and provide the first multiple snapshots of the process. Our approach of utilizing multiple molecules in the crystallographic asymmetric unit should be generally applicable for capturing the dynamic nature of enzymatic catalysis. Copyright Â
© 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21134381      PMCID: PMC3019291          DOI: 10.1016/j.jmb.2010.11.044

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  31 in total

1.  A single residue at the active site of CD38 determines its NAD cyclizing and hydrolyzing activities.

Authors:  R Graeff; C Munshi; R Aarhus; M Johns; H C Lee
Journal:  J Biol Chem       Date:  2001-01-22       Impact factor: 5.157

2.  CD38 expression as a prognostic indicator in chronic lymphocytic leukaemia.

Authors:  Patrick D Thornton; Cristina Fernandez; Giada M Giustolisi; Ricardo Morilla; Shayne Atkinson; Roger P A'Hern; Estella Matutes; Daniel Catovsky
Journal:  Hematol J       Date:  2004

Review 3.  NAADP: An emerging calcium signaling molecule.

Authors:  H C Lee
Journal:  J Membr Biol       Date:  2000-01-01       Impact factor: 1.843

Review 4.  A unified mechanism of enzymatic synthesis of two calcium messengers: cyclic ADP-ribose and NAADP.

Authors:  H C Lee
Journal:  Biol Chem       Date:  1999 Jul-Aug       Impact factor: 3.915

Review 5.  Structures and activities of cyclic ADP-ribose, NAADP and their metabolic enzymes.

Authors:  H C Lee; C Munshi; R Graeff
Journal:  Mol Cell Biochem       Date:  1999-03       Impact factor: 3.396

6.  Identification of the enzymatic active site of CD38 by site-directed mutagenesis.

Authors:  C Munshi; R Aarhus; R Graeff; T F Walseth; D Levitt; H C Lee
Journal:  J Biol Chem       Date:  2000-07-14       Impact factor: 5.157

7.  Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia.

Authors:  R N Damle; T Wasil; F Fais; F Ghiotto; A Valetto; S L Allen; A Buchbinder; D Budman; K Dittmar; J Kolitz; S M Lichtman; P Schulman; V P Vinciguerra; K R Rai; M Ferrarini; N Chiorazzi
Journal:  Blood       Date:  1999-09-15       Impact factor: 22.113

8.  Calculation and use of an HIV-1 disease progression score.

Authors:  B V Roussanov; J M Taylor; J V Giorgi
Journal:  AIDS       Date:  2000-12-01       Impact factor: 4.177

9.  First enzymatic synthesis of an N1-cyclised cADPR (cyclic-ADP ribose) analogue with a hypoxanthine partial structure: discovery of a membrane permeant cADPR agonist.

Authors:  Gerd K Wagner; Steven Black; Andreas H Guse; Barry V L Potter
Journal:  Chem Commun (Camb)       Date:  2003-08-07       Impact factor: 6.222

Review 10.  The metamorphosis of a molecule: from soluble enzyme to the leukocyte receptor CD38.

Authors:  E Ferrero; F Malavasi
Journal:  J Leukoc Biol       Date:  1999-02       Impact factor: 4.962

View more
  6 in total

1.  Porcine CD38 exhibits prominent secondary NAD(+) cyclase activity.

Authors:  Kai Yiu Ting; Christina F P Leung; Richard M Graeff; Hon Cheung Lee; Quan Hao; Masayo Kotaka
Journal:  Protein Sci       Date:  2016-01-12       Impact factor: 6.725

Review 2.  Cyclic ADP-ribose and nicotinic acid adenine dinucleotide phosphate (NAADP) as messengers for calcium mobilization.

Authors:  Hon Cheung Lee
Journal:  J Biol Chem       Date:  2012-07-20       Impact factor: 5.157

Review 3.  Resolving the topological enigma in Ca2+ signaling by cyclic ADP-ribose and NAADP.

Authors:  Hon Cheung Lee; Yong Juan Zhao
Journal:  J Biol Chem       Date:  2019-10-31       Impact factor: 5.157

4.  Insights into the mechanism of bovine CD38/NAD+glycohydrolase from the X-ray structures of its Michaelis complex and covalently-trapped intermediates.

Authors:  Pascal F Egea; Hélène Muller-Steffner; Isabelle Kuhn; Céline Cakir-Kiefer; Norman J Oppenheimer; Robert M Stroud; Esther Kellenberger; Francis Schuber
Journal:  PLoS One       Date:  2012-04-18       Impact factor: 3.240

5.  Synthetic cADPR analogues may form only one of two possible conformational diastereoisomers.

Authors:  Joanna M Watt; Mark P Thomas; Barry V L Potter
Journal:  Sci Rep       Date:  2018-10-15       Impact factor: 4.379

6.  Immuno-targeting the multifunctional CD38 using nanobody.

Authors:  Ting Li; Shali Qi; Mandy Unger; Yun Nan Hou; Qi Wen Deng; Jun Liu; Connie M C Lam; Xian Wang Wang; Du Xin; Peng Zhang; Friedrich Koch-Nolte; Quan Hao; Hongmin Zhang; Hon Cheung Lee; Yong Juan Zhao
Journal:  Sci Rep       Date:  2016-06-02       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.